Reaction

Intestine Transplant Rejection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 96 reports · 3 co-occurring drugs

As of the last recalculation, Intestine Transplant Rejection appears in 96 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 728.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Basiliximab28728.3730.1
Anti-Thymocyte Globulin (Rabbit)6171.9172.1
Sirolimus9159.7159.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.